Finance

Lists
002262:SHE
Jiangsu Nhwa Pharmaceutical Co., LTD
CNÂ¥22.04
+0.09%
(+0.020) 1D
Aug 28, 3:04:48 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002262...
Open
CNÂ¥21.82
High
CNÂ¥22.20
Low
CNÂ¥21.74
Mkt. cap
22.33B
Avg. vol.
13.54M
Volume
5.54M
Dividend
1.81%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 26, 2026
P/E ratio
20.41
52-wk high
CNÂ¥29.30
52-wk low
CNÂ¥17.96
EPS
CNÂ¥1.08
Shares outstanding
1.01B
No. of employees
6K
Open
CNÂ¥21.82
High
CNÂ¥22.20
Low
CNÂ¥21.74
Mkt. cap
22.33B
Avg. vol.
13.54M
Volume
5.54M
Dividend
1.81%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 26, 2026
P/E ratio
20.41
52-wk high
CNÂ¥29.30
52-wk low
CNÂ¥17.96
EPS
CNÂ¥1.08
Shares outstanding
1.01B
No. of employees
6K
About Jiangsu Nhwa Pharmaceutical Co., LTD
CEO-
Employees6K
Founded1978
Headquarters-
SectorPharmaceutical industry
Websitenhwa-group.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.46B
1.44B
1.61B
1.61B
Cost of goods sold
317.02M
606.11M
467.50M
396.41M
Cost of revenue
317.02M
606.11M
467.50M
396.41M
Research and development expenses
176.94M
172.85M
156.79M
155.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
517.01M
740.60M
609.48M
566.49M
Operating expense
707.79M
930.59M
799.18M
738.80M
Total operating expenses
1.02B
1.54B
1.27B
1.14B
Operating income
436.06M
-96.50M
343.58M
472.78M
Other non operating income
-8.77M
11.13M
-1.02M
-4.97M
EBT including unusual items
445.15M
-60.47M
355.72M
490.10M
EBT excluding unusual items
450.14M
-68.49M
361.66M
490.74M
Income tax expense
40.68M
-10.85M
38.12M
67.39M
Effective tax rate
9.14%
17.94%
10.72%
13.75%
Other operating expenses
12.62M
18.65M
17.44M
20.91M
Net income
405.55M
-48.71M
317.41M
423.27M
Net profit margin
27.76%
-3.38%
19.71%
26.32%
Earnings per share
0.40
-0.04
0.31
-
Interest and investment income
24.11M
18.37M
19.53M
19.77M
Interest expense
-733.66K
-460.07K
-426.65K
-635.81K
Net interest expenses
23.37M
17.91M
19.10M
19.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
473.85M
-54.20M
385.87M
520.96M
Gain or loss from assets sale
41.86K
-165.79K
-
-102.56K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps